Pharmaceutical research and development

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about R&D in the pharmaceutical industry

This dossier presents key facts and figures about research and development in the pharmaceutical industry worldwide. The pharmaceutical industry is one of the segments most driven by innovation through research and development investments. This document gives you an overview about pharmaceutical R&D in general, the top companies, characteristics of the current R&D pipeline, and many more.

Table of contents

  • 1. Overview
    • Total global pharmaceutical R&D spending 2012-2026

    • Yearly growth rate of R&D spending in pharmaceutical industry 2005-2019

    • R&D spending growth worldwide on pharmaceuticals 2013-2026

    • Number of drugs in the R&D pipeline worldwide 2001-2020

    • Pharma companies worldwide with active R&D pipelines 2001-2020

    • Projected most valuable R&D projects based on net present value 2020

  • 2. R&D performance by company
    • R&D spending share of top pharmaceutical companies 2019 and 2026

    • Top pharmaceutical companies in R&D spending growth 2019

    • Top 50 global pharmaceutical and biotech companies by R&D intensity in 2019

    • Top pharma companies worldwide 2020, by size of R&D pipeline

    • Distribution of pharmaceutical R&D companies by region 2020

  • 3. Characteristics of R&D pipeline
    • Top therapeutic categories worldwide 2020, by number of R&D products

    • Worldwide top diseases 2020, by number of active drugs

    • Worldwide top origins for pipeline drugs by number of active drugs 2020

    • Worldwide pipeline drugs by delivery route share 2020

    • Worldwide top drug producing mechanisms of action by number of active compounds 2020

  • 4. Costs and ROI
    • R&D cost to develop new pharmaceutical compounds 2010-2019

    • 3 year average R&D cost to develop new pharmaceutical compounds 2010-2019

    • Percentage return on R&D among large cap biopharma companies 2010-2019

    • Percentage return on R&D among mid cap biopharma companies 2013-2019

  • 5. Outsourced R&D
    • Total CRO market size worldwide 2015-2024

    • Global pharma CRO market size 2015-2024, by pre-clinical, clinical and discovery

    • Leading global contract research organizations based on revenue 2019

    • Clinical CRO market size worldwide 2015-2024

    • Size of U.S. healthcare CRO market 2016-2022 by type

  • 6. Opinions on pharma R&D
    • Willingness to pay more taxes for additional medical research - U.S. adults 2019-2020

    • View of health research as a problem or solution for rising costs - U.S. adults 2020

    • U.S. adults impression of the U.S. pharma companies amount of research

    • U.S. adults impression of the U.S. pharma companies quality of research

    • Importance to support private investments in medical research by government 2019

    • Importance of supporting research and innovation to personalize patient care US 2018

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!